INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO)
CUSIP: 45773H409
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 66,777,963
- Total 13F shares
- 112,420
- Share change
- -41,381
- Total reported value
- $195,614
- Price per share
- $1.74
- Number of holders
- 20
- Value change
- -$72,002
- Number of buys
- 3
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 45773H409?
CUSIP 45773H409 identifies INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 45773H409:
Top shareholders of INO - INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
15%
|
9,846,664
|
$19,200,995 | $0 | 28 Nov 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
10%
|
6,666,295
|
$12,999,275 | +$6,630,068 | 28 Nov 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
10%
|
5,517,650
|
$12,911,301 | $0 | 30 Sep 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
9.2%
|
3,633,333
|
$6,794,333 | $0 | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13D/G
|
— |
6%
|
4,000,000
|
$6,400,000 | $0 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5%
from 13D/G
|
3,315,580
|
$5,769,110 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.8%
|
2,553,571
|
$4,443,214 | — | 31 Dec 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
3.6%
|
2,420,122
|
$4,211,012 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.3%
|
2,231,811
|
$3,883,351 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
13D/G
|
— |
2.4%
|
1,314,796
|
$3,076,623 | $0 | 30 Sep 2025 | |
| Stonepine Capital Management, LLC |
13D/G
|
— |
3.8%
|
1,434,997
|
$2,683,444 | -$900,721 | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2.2%
|
1,485,008
|
$2,583,914 | — | 31 Dec 2025 | |
| Jong Joseph Kim |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
3,113,086
mixed-class rows
|
$2,451,149 | — | 11 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.1%
|
1,403,379
|
$2,441,879 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
769,356
|
$1,339,699 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
1.5%
|
537,627
|
$1,099,608 | -$3,642,379 | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.83%
|
553,164
|
$962,505 | — | 31 Dec 2025 | |
| DIADEMA PARTNERS LP |
13F
|
Company |
0.8%
|
533,682
|
$928,607 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.69%
|
459,828
|
$800,000 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
322,739
|
$561,566 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
299,984
|
$521,973 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.38%
|
250,950
|
$436,653 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.37%
|
248,790
|
$432,895 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.37%
|
247,410
|
$430,493 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.33%
|
223,000
|
$388,020 | — | 31 Dec 2025 | |
| Jacqueline E. Shea |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
261,004
mixed-class rows
|
$320,855 | — | 04 Mar 2026 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
173,000
|
$301,020 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.26%
|
170,579
|
$296,808 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.25%
|
167,037
|
$290,644 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.21%
|
142,164
|
$247,365 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.2%
|
130,792
|
$227,578 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.17%
|
115,470
|
$200,918 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
105,828
|
$184,142 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.12%
|
82,331
|
$143,256 | — | 31 Dec 2025 | |
| David B. Weiner |
3/4/5
|
Director |
0.13%
|
87,592
mixed-class rows
|
$142,948 | — | 26 Feb 2026 | |
| Peter Kies |
3/4/5
|
CFO |
—
mixed-class rows
|
93,777
mixed-class rows
|
$129,354 | — | 04 Mar 2026 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.11%
|
73,701
|
$128,240 | — | 31 Dec 2025 | |
| Michael John Sumner |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
70,408
mixed-class rows
|
$127,029 | — | 31 Mar 2026 | |
| Green Alpha Advisors, LLC |
13F
|
Company |
0.11%
|
72,095
|
$125,445 | — | 31 Dec 2025 | |
| Laurent Humeau |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
88,300
mixed-class rows
|
$115,175 | — | 04 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
65,786
|
$114,468 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
58,389
|
$101,597 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.08%
|
50,677
|
$88,178 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.07%
|
50,000
|
$87,000 | — | 31 Dec 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0.07%
|
48,948
|
$85,170 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.07%
|
44,040
|
$77,000 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.06%
|
37,222
|
$64,766 | — | 31 Dec 2025 | |
| Concurrent Investment Advisors, LLC |
13F
|
Company |
0.05%
|
36,011
|
$62,659 | — | 31 Dec 2025 | |
| Lighthouse Investment Partners, LLC |
13F
|
Company |
0.05%
|
30,600
|
$53,244 | — | 31 Dec 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.05%
|
30,500
|
$53,070 | — | 31 Dec 2025 |
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) as of Q1 2026
As of 31 Mar 2026,
INOVIO PHARMACEUTICALS, INC. - Common Stock, $0.001 par value (INO) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,420 shares.
The largest 10 holders included
Green Alpha Advisors, LLC, STEPHENS INC /AR/, Mayflower Financial Advisors, LLC, SIGNATURE ESTATE & INVESTMENT ADVISORS LLC, SBI Securities Co., Ltd., Activest Wealth Management, MJT & Associates Financial Advisory Group, Inc., Root Financial Partners, LLC, Blume Capital Management, Inc., and PITTENGER & ANDERSON INC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
98
Q1 2026 holders
20
Holder diff
-78
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.